Shuttle Pharmaceuticals Holdings Inc., a Rockville company developing treatments to make radiation less harmful for cancer patients, made its debut on a U.S. stock exchange Wednesday after once again adjusting the terms of its initial public offering. The company’s shares began trading on the Nasdaq Capital Market under the symbol “SHPH.” Nasdaq Capital Market is one of three Nasdaq exchanges and is made up of early-stage companies that have relatively low market capitalizations and still need to raise growth capital.
Maryland biotech Shuttle Pharmaceuticals is finally ready for IPO
September 2, 2022